Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) Revenue growth

Alert me on Revenue growth

Chemed Corporation's revenue growth over the twelve months to 30 September 2026 was 5.15%, up 1.1 percentage points from fiscal 2025 (4.06%). Over the past ten years it has ranged from −0.20% (fiscal 2022) to 8.75% (fiscal 2019); the current reading is higher than 36% of that period. That is below the Medical Care Facilities industry median of 6.38% and below the Healthcare sector median of 7.80%.

Revenue growth, annual

Embed this chart

Annual newest first

Period Revenue growth Change (points)
FY2025 4.06% (3.31)
FY2024 7.37% 1.31
FY2023 6.06% 6.26
FY2022 −0.20% (3.07)
FY2021 2.87% (4.40)
FY2020 7.27% (1.48)
FY2019 8.75% 1.79
FY2018 6.96% 1.26
FY2017 5.70% 3.53
FY2016 2.17% (3.81)

Quarterly newest first

Period Revenue growth Change (points)
Sep 2026 10.6% 1.77
Jun 2026 8.80% 7.17
Mar 2026 1.63% 1.73
Dec 2025 −0.10% (3.19)
43 more quarters

Against its own ten years

Low −0.20% High 8.75%
Ten-year median 5.98%
Current reading's percentile 36

Revenue growth against peers

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on CHE